Objective
In the previous Biomed II program, a European concerted action of clinicians and pathologists has been established, to define the clinical characteristics as well as the precise morphological criteria for the sub classification of MCL. Based on this established European infrastructure, we are planning to extend our focus of research to the basic molecular risk factors in MCL. This research network is structured into 4 differentially focussed work packages, each of tem representing an international collaboration of several research groups:
(1) primary genetic alterations and markers of maturation
(2) Cell cycle deregulation in MCL
(3) Secondary alterations and sequential analysis in MCL
(4) Functional studies of MCL.
This approach will identify high-risk patients and finally direct the development of future innovative treatment options.
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
81377 Muenchen
Germany
See on map
Participants (13)
2100 Koepenhagen
See on map
24118 Kiel
See on map
30625 Hannover
See on map
60054 Frankfurt Am-main
See on map
2311 EZ Leiden
See on map
E1 4NS London
See on map
6500 HB Nijmegen
See on map
23538 Luebeck
See on map
Barcelona
See on map
69622 Villeurbanne
See on map
40126 Bologna
See on map
97074 Wuerzburg
See on map
89070 Ulm
See on map